EUROPE: ACTION POINTS
Demanding French patients have driven the emergence of treatments that
offer a more natural result than traditional methods that result in inexpressive
and frozen features. Watch out for the ‘French Touch’ being requested by
patients in other countries.
Non-invasive treatments may be as routine as a trip to the dentist for some
consumers, but there is still a large proportion who say they will never
resort to such procedures. Cosmeceutical brands have a significant
opportunity to
Cosmetic Procedures Market Report 2017: Action Points
A plan of action following the Cosmetic Procedures Market Report 2017, these points will help your business grow in the right direction
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Liposuction regains popularity with consumers
Read moreLipo second most popular US treatment
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more. -
You need to be a subscriber to read this article.
Click here to find out more. -
You need to be a subscriber to read this article.
Click here to find out more.
Upcoming event
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Ingredients
The power of a polyvalent tensor with optimal adhesion
LIFTILIENCE by Silab is a film-forming natural active ingredient derived from chestnuts and obtained using a unique technology. With its optimised tensor effect and adhesion properties, this 6th generation polyvalent tensor offers multiple, rapid and long-lasting cosmetic benefits for the face and body
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.